Sector Alpha Week of 2026-08-05
Sector Alpha — machine-written from the numbers · Data as of 2026-08-05

TeraWulf Inc.

WULF
Financials · Capital Markets

TeraWulf Inc.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.

Biggest watch item: the P/BV sits at the 94th percentile of its own range — the multiple has already done part of the work.

The price is in a confirmed uptrend (53 weeks in) while the P/BV sits at the 94th percentile of its own 5-year range. Underneath, the last four quarters read mixed, with the the net margin at −1,400.0%. What settles it: the next one or two quarters of delivery.

Price
$18.9
+296.6% 1Y
P/BV
56.3×
94th pctile
of its own 5-year range
Revenue (Mar 26)
$0.0 B
+0.0% YoY
Profit (Mar 26)
$−0.4 B
Net margin
−1,400.0%
−1,200.0 pp YoY
ROE
−2,216%
FY25
ROA
−3.42%
latest
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

TeraWulf Inc. trades at $18.9, in a confirmed uptrend and 53 weeks into that stage. That is +7.4% against its own 200-day average. It sits at 50% of a 52-week range of $9 to $29. On relative strength it is currently behind the S&P 500 on a trailing-13-week view (4 weeks and counting).

Today the stock is in a confirmed uptrend — week 53 of stage 2. At $18.9 it trades +7.4% versus its 200-day average and sits at 50% of its 52-week range ($9–$29).

Aug 26: $18.9 Weekly closing price ($) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
+7.4% versus the 200-day line, week 53 of stage 2
Price50-day avg200-day avg
S1S2S1S2$31.2$23.1$15.0$6.9$−1.3$$19$18Jul 23Apr 24Jan 25Oct 25Aug 26
S1S2S1S2$31.2$23.1$15.0$6.9$−1.3$$19$18Jul 23Jan 25Aug 26
Beating or trailing, week by week since 2021 Each cell is one week from 2021 to now (243 weeks): the stock's trailing 13-week return minus the S&P 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the S&P 500 reading is not held.
trailing 13-week return vs the S&P 500
Dec 21Aug 26

Against the market, two honest reads. Cumulative: over the last 4.6 years the stock moved +46% while the S&P 500 moved +68% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (4 weeks and counting; last ahead the week of 2026-07-10) — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation For a bank we price the book, not the earnings: P/BV is what the market pays for each $1 of the bank's net worth. A bank below 1× book is priced below the value of what it owns, net of what it owes.

TeraWulf Inc. trades at 56.3× P/BV, at the pricey end of its own range (94th percentile). Its long-run median P/BV is 4.4×, measured across 4.6 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/BV of 56.3× is at the pricey end of its own range (94th percentile), against a long-run median of 4.4× measured over 4.6 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

The honest context for that discount: a bank earning about −2,216% on its equity is worth less per dollar of book, and the market has priced that in rather than overlooked it. The discount closes only if the returns themselves improve.

P/BV 56.3× vs a 4.4× long-run median P/BV, weekly (left axis); book value per share, quarterly steps drawn weekly (right axis). 4.6-year window; brief peaks above 13× shown pinned at the top. The book value / share bars are red where the reading is lower than the quarter before.
at the pricey end of its own range (94th percentile)
P/BVMedianBook value / share (quarterly)
14.1×$1.410.6×$1.17.1×$0.73.5×$0.40.0×$0.0×$13.10×$0Dec 21Feb 23Apr 24May 25Aug 26
14.1×$1.410.6×$1.17.1×$0.73.5×$0.40.0×$0.0×$13.10×$0Dec 21Apr 24Aug 26
P/BV
56.3×
94th percentile of 5y
PEG
n/m
not derivable — 3-year earnings growth unavailable

The price move, decomposed: over 3y, of the +92.9%/yr price move, ~−19.0%/yr came from book-value growth and ~+111.9 pp from the multiple (expanding). The split is the honest approximate (price return minus book-value growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is full against its own past, so the story rests on the book-value line underneath it, not the multiple.

03 · Stage: No read

Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

TeraWulf Inc. reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 10 quarters across 2 curves, on partial evidence.

Growth, year by year: revenue +21.4% in FY25 Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn.
Revenue YoY
268%202%136%69%3.1%%21.4%FY20FY23FY25
268%202%136%69%3.1%%21.4%FY20FY23FY25
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. Base-effect spikes shown pinned (▲). A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue stabilising
Revenue
323%241%158%76%−6.0%%30.8%Jun 23Sep 24Mar 26
323%241%158%76%−6.0%%30.8%Jun 23Sep 24Mar 26
ROE Annual readings — the quarterly balance-sheet pieces this curve needs are not held for this stock, so the returns read moves once a year and carries less weight in the call.
the return curve, annual readings
ROE
0.0%−248%−503%−758%−1,013%%−942.9%FY22FY23FY25
0.0%−248%−503%−758%−1,013%%−942.9%FY22FY23FY25
Revenue growth
Steady high
latest +30.8% · span +16.7% to +600.0%
ROE
Falling
latest −942.9% · span −942.9%–−63.6%

Why it matters: with too little history, an honest page says so instead of guessing a trajectory.

The latest quarter’s profit carries a one-off item larger than the operating base, so the profit curve is shown but does not vote in the stage call.

Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.

Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; stock price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+21.4%+104.1%+76.2%
Stock price+296.6%+92.9%
Revenue YoY (Mar 26)
+0.0%
latest quarter vs a year ago
Revenue 10y
76.2%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

44.8/100 — rank 16 of 27 in Capital Markets · 55% evidence confidence

TeraWulf Inc. scores 44.8 out of 100 against the 27 companies it is compared with in Capital Markets, ranking 16. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

The four contributions add to the total exactly: 19.3 + 4.4 + 9.8 + 11.3 = 44.8. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if ROA rolls over or gross NPA rises while sector-relative strength deteriorates.

05 · Revenue

Revenue For a bank, revenue is everything the franchise earns — interest on the loan book plus fees from its businesses.

TeraWulf Inc. reported $0.0 B of income in the Mar 26 quarter, +0.0% year on year. Over 5 years it has compounded at 76.2% a year. The last full year, FY25, came in at $0.2 B. The last four reported quarters add to $0.2 B.

FY25 revenue came in at $0.2 B (+21.4% on the year), capping 5 years at 76.2% compound. The latest quarter (Mar 26) printed $0.0 B, +0.0% year on year.

FY25 revenue $0.2 B (+21.4% YoY) Revenue bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
76.2% a year over 5 years
RevenueYoY growth
0.18268%0.14202%0.09136%0.0569%0.003.1%$ B%$0B21.4%FY20FY23FY25
0.18268%0.14202%0.09136%0.0569%0.003.1%$ B%$0B21.4%FY20FY23FY25
Mar 26: $0.0 B (+0.0% YoY) Quarterly revenue bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Revenue (quarterly)YoY growth
0.05326%0.04232%0.03138%0.0143%0.00−51%$ B%$0B0%Jun 23Sep 24Mar 26
0.05326%0.04232%0.03138%0.0143%0.00−51%$ B%$0B0%Jun 23Sep 24Mar 26

Pace check: the last four quarters averaged +31.3% growth against the decade's 76.2% — the current year is running slower than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +30.8% over the last 4 quarters against +30.4%/yr over the last 8 — stabilising.

06 · Net margin

Net margin Net margin — what the bank keeps of every $100 of revenue after every cost, provision and tax. With big fee businesses in the mix, it is the cleanest margin we can read for this bank.

TeraWulf Inc.'s net margin is −1,400.0% in the Mar 26 quarter, −1,200.0 percentage points against the same quarter a year ago. Across 5 fiscal years the net margin has ranged −800.0% to 0.0%. The current quarter is running below every full year in that window.

The latest quarter's net margin is −1,400.0%, −1,200.0 pp against the same quarter a year ago. Across 5 fiscal years the net margin has ranged −800.0%–0.0%.

Why: the numbers show the net margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.

FY25: −776.5% Net margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 5-year window.
within a −800.0–0.0% band over 5 years
net marginYoY change (pp)
64%712%−168%306%−400%−100%−632%−506%−864%−912%%%−776.5%−655.1%FY20FY23FY25
64%712%−168%306%−400%−100%−632%−506%−864%−912%%%−776.5%−655.1%FY20FY23FY25
Mar 26: −1,400.0% net margin (−1,200.0 pp YoY) Quarterly net margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Net profit as a share of total revenue, per quarter.
Net marginYoY change (pp)
85%528%−314%64%−713%−400%−1,111%−864%−1,510%−1,328%%%−1,400%−1,200%Jun 23Sep 24Mar 26
85%528%−314%64%−713%−400%−1,111%−864%−1,510%−1,328%%%−1,400%−1,200%Jun 23Sep 24Mar 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

TeraWulf Inc. posted a net loss of $0.4 B in the Mar 26 quarter. The full FY25 year was a loss of $1.3 B. That loss is 1,400.0% of the quarter's revenue. The same quarter a year earlier lost $0.1 B. 12 of the last 12 reported quarters were loss-making.

Mar 26 profit was $−0.4 B, null year on year. On the full year, FY25 printed $−1.3 B (null).

FY25 profit $−1.3 B (null YoY) Net profit bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
Net profit
0.1−0.3−0.7−1.0−1.4$ B$−1BFY20FY23FY25
0.1−0.3−0.7−1.0−1.4$ B$−1BFY20FY23FY25
Mar 26: $−0.4 B (null YoY) Quarterly net profit bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Net profit (quarterly)
0.0−0.1−0.2−0.4−0.5$ B$−0BJun 23Sep 24Mar 26
0.0−0.1−0.2−0.4−0.5$ B$−0BJun 23Sep 24Mar 26
08 · Asset quality — the ladder

Asset quality — the ladder Gross NPA is the slice of the loan book where repayments have stopped. Net NPA is what remains after the money already set aside against those loans. Falling is healing; rising is damage arriving.

Loan-book quality history is not available for TeraWulf Inc., so this section names the gap rather than estimating a ratio. No gross or net non-performing-asset series is filed in a form this page can read, and none is inferred from the profit line. The income, margin and return sections above carry the evidence this business does report.

We do not hold quarterly loan-book quality numbers for this bank, so this section states that plainly rather than working around it.

Why: loan-book quality is the engine room of a bank, and its drivers — slippages, recoveries, provisioning — sit below what we hold for this name; the sections around it carry the reads we can stand behind.

09 · The loan book

The loan book We read the loan book through revenue — when the book and the businesses grow, revenue grows with them. It is a rough proxy, and we say so: rate moves and fee swings can shift it a few points in any one year.

TeraWulf Inc.'s revenue grew +21.4% in FY25 to $0.2 B, so the book is growing. The latest quarter ran +0.0% year on year. The net margin on that income is −1,400.0%, −1,200.0 percentage points against a year ago. Interest income is a proxy for the book; rate moves can shift it a few points in any one year.

FY25 revenue was $0.2 B, +21.4% on the year, and the latest quarter ran +0.0% year on year. The net margin on that revenue is −1,400.0% this quarter (−1,200.0 pp YoY) — growth with a narrowing margin on it.

FY25: revenue $0.2 B (+21.4% YoY) with the net margin at −776.5% Revenue by fiscal year, $ B (bars, left); net margin, % (line, right). 5-year window. A bar is red when it is lower than the year before.
RevenueNet margin
0.1864%0.14−168%0.09−400%0.05−632%0.00−864%$ B%$0B−776.5%FY20FY22FY23FY24FY25
0.1864%0.14−168%0.09−400%0.05−632%0.00−864%$ B%$0B−776.5%FY20FY23FY25

The synthesis: a lender compounds when the book grows while the margin holds and the loan book stays clean — with quarterly loan-quality numbers missing here, revenue growth and margin are the two we watch.

10 · Returns on equity and assets

Returns on equity and assets Two numbers rate a bank: ROE — what it earns on shareholder money — and ROA — what it earns on everything it deploys. ROE above ~13–15% earns its keep; below that, growth builds book slowly.

TeraWulf Inc. earns a return on equity of −943% in FY25. Its trough over the ladder below was −943% in FY25. On the asset side every $100 of the balance sheet earned about $−3.42, which is the return before leverage is applied.

FY25 ROE came in at −943%. On assets, the latest reading is about −3.42% — every $100 the bank deploys earns roughly $−3.42 a year. That return is below the bar a bank must clear to compound book value quickly — which is also the honest reason the stock trades where it does.

FY25: ROE −943%, ROA −5.10% Return on equity by fiscal year, % (line, left); return on assets, % (line, right). 4-year window. A lender is judged on ROE and ROA — return on invested capital does not apply to a bank.
the full ladder
ROEROA
0.0%−4.3%−248%−7.2%−503%−10%−758%−13%−1,013%−16%%%−942.9%−5.1%FY22FY23FY25
0.0%−4.3%−248%−7.2%−503%−10%−758%−13%−1,013%−16%%%−942.9%−5.1%FY22FY23FY25
Mar 26: ROE −897.3% (TTM), ROA −4.10% Trailing-twelve-month return on equity (left) and on assets (right), per quarter, %. Last 12 quarters, anchored to the annual figure.
ROE (TTM)ROA (TTM)
67%0.0%−192%−2.6%−451%−5.1%−710%−7.7%−969%−10%%%−897.3%−4.1%Jun 23Sep 24Mar 26
67%0.0%−192%−2.6%−451%−5.1%−710%−7.7%−969%−10%%%−897.3%−4.1%Jun 23Sep 24Mar 26

Why: the ROE ladder shows the move; the deposit-cost and provisioning drivers behind it sit below what we hold.

11 · Dividend

Dividend

TeraWulf Inc. pays no dividend. Across the last 12 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.

TeraWulf Inc. does not currently pay a dividend. Across the last 12 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.

12 · Debt

Debt

For a bank, borrowings are raw material, not a warning sign — solvency is read through the returns and the loan book. A manufacturer’s debt is a claim against its profits, so the debt-to-equity lens that works everywhere else misleads on a lender and is not applied here.

A manufacturer’s debt is a claim against its profits; a bank’s borrowings are its inventory — money taken in to be lent out. The debt lens that works everywhere else misleads here, so this page does not apply it. The solvency questions for a bank — is the loan book sound, is the equity earning — are read through the loan-book and returns sections above.

13 · Ownership

Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.

27.3% of TeraWulf Inc.'s tradable float is currently sold short — a large bloc is positioned against it. At typical trading volumes those positions would take about 2.9 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.

The latest reading: 27.3% of the float is sold short, and at typical trading volumes it would take about 2.9 days to buy those positions back. A large bloc is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.

Short interest
27.3%
of the tradable float
Days to cover
2.9
at typical volumes

Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.

14 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

TeraWulf Inc.: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre. The Z-score was built for manufacturers and is not applied to banks and lenders, so solvency here is read from the capital and asset-quality lines instead.

The safety line in one sentence: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre.

15 · Related companies · Capital Markets
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Marex Group LimitedMRX 65.0/100Favorable setup76% evidence LEADER 24.0/35 Income 32.6% · PAT 40.9% 71% evidence 12.4/25 ROA 0.6% · ROE 9.4% · GNPA — 68% evidence 9.5/20 P/BV 2.56× · P/BV÷ROE 0.27 70% evidence 19.1/20 RS sector 33.4% · RS bench 31.9% · 1Y 81.1%12 of 12 weeks ahead 100% evidence
Exact sum: 24 + 12.4 + 9.5 + 19.1 = 65 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
2Morgan StanleyMS 63.1/100Mixed-positive evidence80% evidence LEADER 21.1/35 Income 18% · PAT 36.8% 81% evidence 13.7/25 ROA 0.8% · ROE 10.3% · GNPA — 68% evidence 11.3/20 P/BV 2.27× · P/BV÷ROE 0.22 70% evidence 17.0/20 RS sector 10.2% · RS bench 9% · 1Y 51.6%12 of 12 weeks ahead 100% evidence
Exact sum: 21.1 + 13.7 + 11.3 + 17 = 63.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
3Virtu Financial, Inc.VIRT 63.0/100Mixed-positive evidence60% evidence LEADER 14.1/35 Income — · PAT — 26% evidence 16.8/25 ROA 1.3% · ROE 14.4% · GNPA — 68% evidence 13.9/20 P/BV 2.21× · P/BV÷ROE 0.15 70% evidence 18.2/20 RS sector 19.7% · RS bench 18.4% · 1Y 34.3%12 of 12 weeks ahead 100% evidence
Exact sum: 14.1 + 16.8 + 13.9 + 18.2 = 63 · Decision use: Price leads the evidence: RS versus the benchmark is 18.4%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
4StoneX Group Inc.SNEX 62.2/100Mixed-positive evidence62% evidence FADING 24.5/35 Income 38% · PAT 56.1% 55% evidence 13.0/25 ROA — · ROE 7.6% · GNPA — 34% evidence 8.0/20 P/BV 2.36× · P/BV÷ROE 0.31 70% evidence 16.7/20 RS sector 22.5% · RS bench 21% · 1Y 89.6%9 of 12 weeks ahead 100% evidence
Exact sum: 24.5 + 13 + 8 + 16.7 = 62.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
5The Charles Schwab CorporationSCHW 60.9/100Mixed-positive evidence80% evidence TURNING 22.8/35 Income 20.3% · PAT 38.6% 81% evidence 15.6/25 ROA 1.2% · ROE 11.3% · GNPA — 68% evidence 8.7/20 P/BV 3.32× · P/BV÷ROE 0.29 70% evidence 13.8/20 RS sector 0.8% · RS bench -0.1% · 1Y 9.5%4 of 12 weeks ahead 100% evidence
Exact sum: 22.8 + 15.6 + 8.7 + 13.8 = 60.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6Piper Sandler CompaniesPIPR 52.6/100Mixed-positive evidence60% evidence BASING 21.7/35 Income — · PAT — 26% evidence 18.1/25 ROA 7.2% · ROE 10% · GNPA — 68% evidence 7.0/20 P/BV 3.87× · P/BV÷ROE 0.39 70% evidence 5.8/20 RS sector -15.8% · RS bench -16.7% · 1Y -5.7%0 of 12 weeks ahead 100% evidence
Exact sum: 21.7 + 18.1 + 7 + 5.8 = 52.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
7Evercore Inc.EVR 51.5/100Mixed-positive evidence60% evidence BASING 20.9/35 Income — · PAT — 26% evidence 18.9/25 ROA 6.1% · ROE 11.1% · GNPA — 68% evidence 5.8/20 P/BV 6.48× · P/BV÷ROE 0.58 70% evidence 5.9/20 RS sector -12% · RS bench -12.9% · 1Y 8.1%4 of 12 weeks ahead 100% evidence
Exact sum: 20.9 + 18.9 + 5.8 + 5.9 = 51.5 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression.
8PJT Partners Inc.PJT 50.4/100Mixed-positive evidence60% evidence TURNING 20.0/35 Income — · PAT — 26% evidence 17.4/25 ROA 5% · ROE 8.9% · GNPA — 68% evidence 3.5/20 P/BV 12.38× · P/BV÷ROE 1.39 70% evidence 9.5/20 RS sector -5.6% · RS bench -6.6% · 1Y -3%4 of 12 weeks ahead 100% evidence
Exact sum: 20 + 17.4 + 3.5 + 9.5 = 50.4 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression.
9LPL Financial Holdings Inc.LPLA 49.4/100Mixed-negative evidence60% evidence TURNING 16.4/35 Income — · PAT — 26% evidence 15.3/25 ROA 2.4% · ROE 7% · GNPA — 68% evidence 6.4/20 P/BV 3.91× · P/BV÷ROE 0.56 70% evidence 11.3/20 RS sector -3.6% · RS bench -4.4% · 1Y -4.2%2 of 12 weeks ahead 100% evidence
Exact sum: 16.4 + 15.3 + 6.4 + 11.3 = 49.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
10The Goldman Sachs Group, Inc.GS 48.8/100Mixed-negative evidence80% evidence BREAKING OUT 16.8/35 Income 17.8% · PAT 34.8% 81% evidence 9.2/25 ROA 0.3% · ROE 5.4% · GNPA — 68% evidence 7.2/20 P/BV 2.03× · P/BV÷ROE 0.38 70% evidence 15.6/20 RS sector 7.6% · RS bench 6.4% · 1Y 46%10 of 12 weeks ahead 100% evidence
Exact sum: 16.8 + 9.2 + 7.2 + 15.6 = 48.8 · Decision use: Price leads the evidence: RS versus the benchmark is 6.4%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
11Interactive Brokers Group, Inc.IBKR 48.0/100Mixed-negative evidence60% evidence FADING 16.8/35 Income — · PAT — 26% evidence 10.8/25 ROA 0.6% · ROE 6.6% · GNPA — 68% evidence 5.0/20 P/BV 6.57× · P/BV÷ROE 0.99 70% evidence 15.4/20 RS sector 9.2% · RS bench 8% · 1Y 34.5%10 of 12 weeks ahead 100% evidence
Exact sum: 16.8 + 10.8 + 5 + 15.4 = 48 · Decision use: Price leads the evidence: RS versus the benchmark is 8%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
12Stifel Financial Corp.SF 46.7/100Mixed-negative evidence60% evidence TURNING 16.2/35 Income — · PAT — 26% evidence 8.4/25 ROA -2% · ROE 8.1% · GNPA — 68% evidence 11.0/20 P/BV 1.9× · P/BV÷ROE 0.23 70% evidence 11.1/20 RS sector -2.2% · RS bench -3.1% · 1Y 12.9%1 of 12 weeks ahead 100% evidence
Exact sum: 16.2 + 8.4 + 11 + 11.1 = 46.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
13Moelis & CompanyMC 46.6/100Mixed-negative evidence60% evidence TURNING 17.5/35 Income — · PAT — 26% evidence 16.5/25 ROA 3.9% · ROE 8.9% · GNPA — 68% evidence 4.3/20 P/BV 9.58× · P/BV÷ROE 1.08 70% evidence 8.3/20 RS sector -6.9% · RS bench -7.8% · 1Y -1.9%4 of 12 weeks ahead 100% evidence
Exact sum: 17.5 + 16.5 + 4.3 + 8.3 = 46.6 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression.
14Jefferies Financial Group Inc.JEF 45.1/100Mixed-negative evidence80% evidence BREAKING OUT 21.6/35 Income 21.4% · PAT 39.5% 81% evidence 8.5/25 ROA 0.3% · ROE 2.4% · GNPA — 68% evidence 6.7/20 P/BV 1.01× · P/BV÷ROE 0.42 70% evidence 8.3/20 RS sector -8.5% · RS bench -9.5% · 1Y -4.7%9 of 12 weeks ahead 100% evidence
Exact sum: 21.6 + 8.5 + 6.7 + 8.3 = 45.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
15MarketAxess Holdings Inc.MKTX 45.0/100Mixed-negative evidence60% evidence TURNING 15.1/35 Income — · PAT — 26% evidence 14.8/25 ROA 3.1% · ROE 5.1% · GNPA — 68% evidence 6.0/20 P/BV 3.26× · P/BV÷ROE 0.64 70% evidence 9.1/20 RS sector -10.1% · RS bench -10.8% · 1Y -13.2%1 of 12 weeks ahead 100% evidence
Exact sum: 15.1 + 14.8 + 6 + 9.1 = 45 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
16TeraWulf Inc.this pageWULF 44.8/100Thin evidence · provisional55% evidence FADING 19.3/35 Income 28% · PAT — 45% evidence 4.4/25 ROA -4.1% · ROE -897.3% · GNPA — 68% evidence 9.8/20 P/BV -77.86× · P/BV÷ROE — 10% evidence 11.3/20 RS sector 7.5% · RS bench 6% · 1Y 275.3%8 of 12 weeks ahead 100% evidence
Exact sum: 19.3 + 4.4 + 9.8 + 11.3 = 44.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
17BGC Group, Inc.BGC 43.9/100Mixed-negative evidence60% evidence BASING 16.8/35 Income — · PAT — 26% evidence 9.2/25 ROA 0.4% · ROE 5.8% · GNPA — 68% evidence 5.5/20 P/BV 4.63× · P/BV÷ROE 0.8 70% evidence 12.4/20 RS sector 1.1% · RS bench 0.1% · 1Y 9.2%5 of 12 weeks ahead 100% evidence
Exact sum: 16.8 + 9.2 + 5.5 + 12.4 = 43.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
18Tradeweb Markets Inc.TW 42.5/100Mixed-negative evidence60% evidence BASING 18.5/35 Income — · PAT — 26% evidence 13.8/25 ROA 2.3% · ROE 2.9% · GNPA — 68% evidence 4.8/20 P/BV 3.17× · P/BV÷ROE 1.09 70% evidence 5.4/20 RS sector -17.9% · RS bench -18.6% · 1Y -25.8%0 of 12 weeks ahead 100% evidence
Exact sum: 18.5 + 13.8 + 4.8 + 5.4 = 42.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
19Riot Platforms, Inc.RIOT 42.3/100Thin evidence · provisional55% evidence FADING 15.3/35 Income 42.3% · PAT — 45% evidence 4.5/25 ROA -14% · ROE -18.7% · GNPA — 68% evidence 9.8/20 P/BV 1.96× · P/BV÷ROE — 10% evidence 12.7/20 RS sector 9.9% · RS bench 8.3% · 1Y 94.6%10 of 12 weeks ahead 100% evidence
Exact sum: 15.3 + 4.5 + 9.8 + 12.7 = 42.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
20Galaxy Digital Inc.GLXY 39.7/100Thin evidence · provisional53% evidence ASLEEP 22.4/35 Income 25.5% · PAT — 45% evidence 5.5/25 ROA -2.8% · ROE -10.6% · GNPA — 68% evidence 10.0/20 P/BV — · P/BV÷ROE — 0% evidence 1.8/20 RS sector -24.8% · RS bench -25.9% · 1Y -20.3%7 of 12 weeks ahead 100% evidence
Exact sum: 22.4 + 5.5 + 10 + 1.8 = 39.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
21Robinhood Markets, Inc.HOOD 38.6/100Mixed-negative evidence60% evidence BREAKING OUT 17.1/35 Income — · PAT — 26% evidence 10.9/25 ROA 1% · ROE 6.5% · GNPA — 68% evidence 3.4/20 P/BV 9.51× · P/BV÷ROE 1.46 70% evidence 7.2/20 RS sector -17.2% · RS bench -18.1% · 1Y -18.4%10 of 12 weeks ahead 100% evidence
Exact sum: 17.1 + 10.9 + 3.4 + 7.2 = 38.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
22Houlihan Lokey, Inc.HLI 36.3/100Mixed-negative evidence60% evidence BASING 14.3/35 Income — · PAT — 26% evidence 13.8/25 ROA 2% · ROE 3.5% · GNPA — 68% evidence 4.4/20 P/BV 4.11× · P/BV÷ROE 1.17 70% evidence 3.8/20 RS sector -30.6% · RS bench -31.2% · 1Y -32.1%0 of 12 weeks ahead 100% evidence
Exact sum: 14.3 + 13.8 + 4.4 + 3.8 = 36.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
23IREN LimitedIREN 32.5/100Thin evidence · provisional55% evidence ASLEEP 16.3/35 Income 100% · PAT — 45% evidence 4.8/25 ROA -4.9% · ROE -12.1% · GNPA — 68% evidence 9.6/20 P/BV 4.39× · P/BV÷ROE — 10% evidence 1.8/20 RS sector -17.2% · RS bench -18.4% · 1Y 121.4%6 of 12 weeks ahead 100% evidence
Exact sum: 16.3 + 4.8 + 9.6 + 1.8 = 32.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
24Circle Internet Group, Inc.CRCL 25.7/100Adverse evidence70% evidence ASLEEP 12.5/35 Income 51.4% · PAT -146.2% 71% evidence 6.6/25 ROA 0.1% · ROE 2.1% · GNPA — 68% evidence 3.2/20 P/BV 6.89× · P/BV÷ROE 3.28 70% evidence 3.4/20 RS sector -40.6% · RS bench -41.2% · 1Y -60.2%2 of 12 weeks ahead 70% evidence
Exact sum: 12.5 + 6.6 + 3.2 + 3.4 = 25.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
25Figure Technology Solutions, Inc.FIGR 52.6/100Thin evidence · provisional47% evidence ASLEEP 23.8/35 Income 67.8% · PAT 100% 45% evidence 13.9/25 ROA 2.4% · ROE 5.4% · GNPA — 68% evidence 4.9/20 P/BV 5.76× · P/BV÷ROE 1.07 70% evidence 10.0/20 RS sector — · RS bench — · 1Y —2 of 12 weeks ahead 0% evidence
Exact sum: 23.8 + 13.9 + 4.9 + 10 = 52.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
26Hut 8 Corp.HUT 52.2/100Thin evidence · provisional41% evidence FADING 19.4/35 Income 100% · PAT — 29% evidence 8.7/25 ROA — · ROE -18.9% · GNPA — 34% evidence 9.8/20 P/BV 3.83× · P/BV÷ROE — 10% evidence 14.3/20 RS sector 47.6% · RS bench 45.2% · 1Y 420.1%11 of 12 weeks ahead 100% evidence
Exact sum: 19.4 + 8.7 + 9.8 + 14.3 = 52.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
27Bitmine Immersion Technologies, Inc.BMNR 35.2/100Thin evidence · provisional42% evidence BASING 16.2/35 Income — · PAT — 26% evidence 6.2/25 ROA 0.2% · ROE -1.4% · GNPA — 68% evidence 9.8/20 P/BV 0.96× · P/BV÷ROE — 10% evidence 3.0/20 RS sector -45.2% · RS bench -45.8% · 1Y -64.8%0 of 12 weeks ahead 70% evidence
Exact sum: 16.2 + 6.2 + 9.8 + 3 = 35.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

16 · Frequently asked questions

Frequently asked questions

What is TeraWulf Inc.'s stock price today?

TeraWulf Inc. trades at $18.9, +296.6% over the past year. The company is valued at $9.0 B. The stock sits at 50% of its 52-week range of $9–$29, +7.4% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 53 weeks in. — as of 5 August 2026.

What were TeraWulf Inc.'s latest quarterly results?

TeraWulf Inc. reported total income of $0.0 B and a net loss of $0.4 B for the Mar 26 quarter. Earnings per share were $−1.01. The net margin was −1,400.0%, 1,200.0 pp lower than a year earlier. — as of 5 August 2026.

What is TeraWulf Inc.'s revenue?

TeraWulf Inc. reported revenue of $0.0 B in the Mar 26 quarter, +0.0% year on year. For the full FY25 fiscal year, revenue was $0.2 B (+21.4%). Over the last 5 years revenue compounded at 76.2% a year. — as of 5 August 2026.

What is TeraWulf Inc.'s profit?

TeraWulf Inc. earned $−0.4 B of net profit in the Mar 26 quarter. Full-year FY25 profit was $−1.3 B. The net margin ran −1,400.0% in the latest quarter. — as of 5 August 2026.

What is TeraWulf Inc.'s market cap?

TeraWulf Inc.'s market capitalisation is $9.0 B at a stock price of $18.9. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.

What is TeraWulf Inc.'s P/BV ratio?

TeraWulf Inc. trades at a P/BV of 56.3×, at the 94th percentile of its own 5-year range, against a long-run median of 4.4×. This is a comparison with the stock's own history, not a value call — as of 5 August 2026.

Does TeraWulf Inc. pay a dividend?

No — TeraWulf Inc. has declared no dividend per share in any of its last 12 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 5 August 2026.

Is TeraWulf Inc. overvalued?

On its own history, TeraWulf Inc. looks expensive against its own history: its P/BV of 56.3× sits at the 94th percentile of its 5-year range (long-run median 4.4×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 5 August 2026.

How is TeraWulf Inc. performing?

TeraWulf Inc. is in a confirmed uptrend, 53 weeks in. Against the S&P 500 it has been behind on a trailing-13-week view for 4 weeks. This describes what the data did, not a rating. — as of 5 August 2026.

Is TeraWulf Inc. in an uptrend?

Yes — the price is in a confirmed uptrend (week 53 of stage 2), trading +7.4% versus its 200-day average and at 50% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 5 August 2026.

Is TeraWulf Inc. beating the market?

Not lately — on a trailing-13-week view TeraWulf Inc. is currently behind the S&P 500 (4 weeks and counting; last ahead the week of 2026-07-10), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 4.6 years the stock moved +46% against the S&P 500's +68% — behind the index over the full window. — as of 5 August 2026.

Will TeraWulf Inc.'s stock price go up?

This page publishes no price forecast for TeraWulf Inc. What it measures instead: the stock price is $18.9, the price is in a confirmed uptrend 53 weeks in. Its P/BV of 56.3× sits at the 94th percentile of its own 5-year range. — as of 5 August 2026.

Is the market betting against TeraWulf Inc.?

Yes — short interest is 27.3% of TeraWulf Inc.'s tradable float, about 2.9 days to cover at typical volumes. A crowded short: a large bloc is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 5 August 2026.

Is TeraWulf Inc.'s loan book healthy?

We do not hold quarterly loan-book quality numbers for TeraWulf Inc., so this page says that plainly. The cleanest available reads are revenue growth (+21.4% in FY25) and the net margin on it (−1,400.0%) — as of 5 August 2026.

Where is TeraWulf Inc. in its business cycle?

TeraWulf Inc.'s FY25 net margin was −776.5%, against a 5-year band of −800.0%–0.0%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran −1,400.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.

What could break the TeraWulf Inc. story?

Biggest watch item: the P/BV sits at the 94th percentile of its own range — the multiple has already done part of the work. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.

Is TeraWulf Inc. a stock worth studying right now?

This is not investment advice. The machine read: TeraWulf Inc.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI